KUALA LUMPUR, Sept 6 (Bernama) -- The National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia (MOH) would like to urge the public to avoid buying and using this traditional product which has been detected to contain glibenclamide, a scheduled poison:



Following this, registration of this product has been cancelled by the Drug Control Authority (DCA) at its 338^th meeting on 5 September 2019. Any scheduled poison is not allowed to be formulated in a product which is classified as a traditional product.
 
ABOUT SCHEDULED POISON
 
Glibenclamide is a scheduled poison and the supply of medicines with scheduled poisons is subjected to the Poisons Act 1952, whereby it can only be supplied by a registered medical practitioner or a licensed pharmacist. The use of glibenclamide without healthcare professional supervision can cause excessively low blood glucose which may eventually lead to seizure or loss of consciousness.
 
WARNING
 
All sellers and distributors are warned to stop the sales and distribution of this product. Possession for sale and distribution of this product violates the Sale of Drugs Act 1952 and Control of Drugs and Cosmetics Regulations 1984.
 
An individual found convicted under these laws will face penalty not exceeding RM25,000 and or imprisonment for a period not exceeding three (3) years for the first offence and penalty not exceeding RM50,000 and or imprisonment for a period not exceeding five (5) years for a subsequent offence. A company found guilty can be fined up to RM50,000 for the first offence and a fine of up to RM100,000 for a subsequent offence.
 
Members of the public who experience discomfort or adverse effects after taking these products are advised to immediately stop using it and seek further advice from healthcare professionals.

 

Members of the public can check the registration status of a product by visiting NPRA’s webpage www.npra.gov.my or download the “NPRA Product Status” application from Google Play Store.
 
Please click here for Appendix
 
Datuk Dr. Noor Hisham bin Abdullah
Director General of Health Malaysia
6 September 2019

Source: Ministry of Health

FOR MORE INFORMATION, PLEASE CONTACT:
Name: BAHARUDIN BIN MOHAMAD
Pegawai Perhubungan Awam
Unit Komunikasi Korporat
Kementerian Kesihatan Malaysia
Tel : 03-88834536 / 017-2635008

--BERNAMA